Communicable diseases are easily spread from person to person. Prompt reporting of a communicable disease can allow public health officials to locate and treat exposed persons, identify and contain outbreaks, and interrupt disease transmission. The information obtained from disease reporting is also used to monitor disease trends, identify high risk groups, develop policy, and design prevention programs.
Please note: all positive and negative molecular (PCR) and antibody test results for SARS-CoV-2 (COVID-19) are reportable to TDH.
Health and Human Services (HHS) recently sent out a letter titled COVID-19 Pandemic Response, Laboratory Data Reporting: CARES Act Section 18115 (June 4, 2020). This letter was intended to support and compel the electronic reporting of laboratory results for all COVID test and result types. In the documents below, TDH explains how the agency is responding to these new HHS requirements and expectations of partners conducting laboratory testing for COVID. Please review the memo and consult the FAQs for additional insight. TDH will regularly update the FAQs and guidance documents once the national technical guidance is released.
2020 Reporting Guidance - *Effective January 1, 2020
An excerpt of Reportable Diseases Rule and Regulations is below. Click a here for the full guidance.
1200-14-01-.02 REPORTABLE DISEASES.
- All healthcare providers and other persons knowing of or suspecting a case, culture, or specimen of a reportable disease or event shall report that occurrence to the Department of Health in the time and manner set forth by the Commissioner in the List.
- The Commissioner shall re-evaluate, update, and post the List at least annually and from time to time as appropriate. The Commissioner shall post the annual update on or before November 15th of each year and this new List shall become effective starting January 1st of the following year. If the Commissioner posts an updated List more frequently than on an annual basis, then the updated List will become effective on the date stated in the List. The List shall be available online at the Department of Health’s web page and in print.
Regional health office e-mail addresses and contact numbers:
The Tennessee Department of Health Laboratory Services consists of the Microbiology Laboratories and Environmental Laboratories in Nashville and Knoxville.
For details on which diseases, events, or conditions, have requested or required submission to the state public health laboratory, along with submission requirements, refer to the Detailed Laboratory Guidance document. Additional information about submission requirements, including forms, is available at https://www.tn.gov/health/health-program-areas/lab.html. In addition, a directory of services is available at https://www.tn.gov/health/health-program-areas/lab/directory-of-services.html.
Division of Laboratory Services
630 Hart Lane
Nashville, Tennessee 37243
Phone: (615) 262-6300
Fax: (615) 262-6393
1522 Cherokee Trail
Knoxville, TN 37920
Phone: (865) 549-5201
Fax: (865) 594-5199
Alphabetical listing of reportable diseases and events including description, reporting requirements, laboratory testing algorithms, case definitions, investigation protocols, and report forms.
Surveillance data and summary reports for most reportable diseases and events are found here https://tn.gov/health/ceds-weeklyreports.html.
California Serogroup/LaCrosse virus infection
Candida auris (including rule-out Candida auris)
Campylobacteriosis (including EIA or PCR positive stools)
Carbon Monoxide Poisoning
Colistin-Resistant (Plasmid-Mediated) Gram Negative Bacteria
Congenital Rubella Syndrome
Haemophilus influenzae Invasive Disease
Hansen's disease (Leprosy)
Healthcare Associated Infections, Catheter-Associated Urinary Tract Infections
Healthcare Associated Infections, Central Line Associated Bloodstream Infections
Healthcare Associated Infections, Clostridium difficile Infections
Healthcare Associated Infections, Dialysis Events
Healthcare Associated Infections, Healthcare Personnel Influenza Vaccination
Healthcare Associated Infections, Methicillin Resistant Staphylococcus aureus positive blood cultures
Healthcare Associated Infections, Surgical Site Infections
Healthcare Associated Infections, Ventilator Associated Events
Hemolytic Uremic Syndrome (HUS)
Hepatitis, Viral-HBsAg positive infant
Hepatitis, Viral-HBsAg positive pregnant female
Hepatitis, Viral-Type A acute
Hepatitis, Viral-Type B acute
Hepatitis, Viral-Type C acute
Human Immunodeficiency Virus (HIV)
HUS (Hemolytic Uremic Syndrome)
Methicillin Resistant Staphylococcus aureus (Invasive Disease)
Middle East Respiratory Syndrome (MERS)
Mycobacterium nontuberculous species-extra-pulmonary only
Salmonellosis: Other than Typhoid fever
Salmonellosis: Typhoid fever
Shiga-toxin producing Escherichia coli (including Shiga-like toxin positive stools, E. coli O157, E. coli non-O157)
Spotted Fever Rickettsiosis
St. Louis Encephalitis virus infection
Staphylococcal Enterotoxin B (SEB) Pulmonary Poisoning
Staphylococcus aureus: Methicillin Resistant Invasive Disease
Streptococcus pneumoniae Invasive Disease (IPD)
Staphylococcus aureus: Vancomycin non-sensitive - all forms
Vancomycin Non-Sensitive Staphylococcus aureus (All forms)
Vancomycin Resistant Enterocci (VRE) Invasive Disease
Venezuelan Equine Encephalitis virus infection
Viral Hemorrhagic Fever